Is hormone therapy tied to lower brain SVD? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Is hormone therapy tied to lower brain SVD?

  • By

  • Andrea Surnit

  • November 18, 2026

  • 4 min

Share

Clinical Scorecard: Is hormone therapy tied to lower brain SVD?

At a Glance

CategoryDetail
ConditionCerebral small vessel disease (SVD) burden and white matter integrity in cognitively unimpaired older women
Key MechanismsThe study examined associations of reproductive lifespan, oral contraceptive use, and menopausal hormone therapy (MHT) with MRI measures of SVD and white matter integrity; it did not establish causal mechanisms.
Target Population352 women in the Gothenburg H70-1944 Birth Cohort in Sweden, imaged at a mean age of 70.8 years; 205 had repeat imaging about 5 years later.
Care SettingObservational brain MRI research; the findings were described by the authors as contributing to mechanistic understanding rather than immediate clinical translation.

Key Highlights

  • MHT use was associated with 59% lower odds of at least 2 SVD markers and greater white matter integrity; both associations remained significant after multiple-comparison correction.
  • Each additional year of reproductive lifespan was associated with 8% lower odds of at least 2 SVD markers, but this association did not remain significant after correction; later menopause accounted for the association in further analyses.
  • Women reporting both OC and MHT use had 69% lower odds of at least 2 SVD markers and greater white matter integrity than women reporting neither; both associations remained significant after correction.
  • No statistically significant multiplicative interaction between OC and MHT use was found.
  • Longitudinal analyses found no significant associations between reproductive lifespan or hormone therapy use and changes in cortical thickness or white matter hyperintensity volume over about 5 years.

Guideline-Based Recommendations

Diagnosis

  • The study assessed SVD burden using white matter hyperintensities, lacunes, cerebral microbleeds, and enlarged perivascular spaces on MRI.
  • White matter integrity was assessed using fractional anisotropy derived from diffusion tensor imaging.

Management

  • The study does not provide treatment recommendations; its authors stated that the findings should not be interpreted as immediate clinical translation.

Monitoring & Follow-up

  • Repeat MRI was available for 205 participants about 5 years after baseline imaging.
  • No statistically significant associations were found between reproductive lifespan or hormone therapy use and longitudinal changes in cortical thickness or white matter hyperintensity volume.

Risks

  • The observational design cannot establish causality or determine whether imaging differences translate into cognitive benefits.
  • Hormonal histories were retrospective and self-reported, with limited information on treatment formulation, dose, route, duration, and timing.
  • The small longitudinal imaging sample and follow-up attrition may have reduced the ability to detect associations; findings may not generalize beyond cognitively unimpaired older Swedish women.

Patient & Prescribing Data

Cognitively unimpaired older women in a Swedish birth cohort; mean age at baseline MRI was 70.8 years.

Self-reported MHT use was associated with lower odds of multiple SVD markers and greater white matter integrity. The study does not establish causality or support prescribing conclusions.

Clinical Best Practices

  • Interpret the reported hormone exposure associations as observational findings, not evidence of a causal treatment effect.
  • Do not infer cognitive benefit from the imaging associations; the study found no significant overall associations with Alzheimer's disease-related cortical thickness or abnormal cerebrospinal fluid biomarkers.
  • Consider the study's limited treatment-history detail and population when assessing applicability to other patients.

Related Resources & Content

Original Source(s)

Related Content